​

Funding Round

Series A - Cadence Neuroscience

Series A - Cadence Neuroscience

Investment Firm

Overview

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Announced Date

Oct 11, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Jazz Venture Partners

Jazz Venture Partners

Jazz Venture Partners is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorMayo Clinic Ventures
Participant InvestorJazz Venture Partners

Round Details and Background

Cadence Neuroscience raised $15000000 on 2019-10-11 in Series A

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 11, 2019
Series A - Cadence Neuroscience
2-15.0M
Oct 11, 2019
Grant - Cadence Neuroscience
1-undefined
Feb 28, 2023
Series B - Cadence Neuroscience
6-26.0M

Recent Activity

There is no recent news or activity for this profile.